Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
34%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
61%
ALSO IN FTXH
FTXH
51
HOLDINGS
35%
ALSO IN PBE
SECTOR DRIFT (PBE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 5.5% | 4.1% | 4.1% |
|
REGENERON PHARMACEUTICALS | 4.8% | 4.1% | 4.1% |
|
AMGEN INC | 4.8% | 3.7% | 3.7% |
|
GILEAD SCIENCES INC | 4.6% | 3.4% | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 4.9% | 3.4% | 3.4% |
PBE Overweight Relative to FTXH
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
IONIS PHARMACEUTICALS, INC. | 3.4% |
|
INCYTE CORP | 3.2% |
|
SAREPTA THERAPEUTICS INC | 3.2% |
|
VERACYTE INC | 3.2% |
|
EXACT SCIENCES CORP | 3.1% |
|
ILLUMINA INC | 2.8% |
|
BIO-TECHNE CORPORATION | 2.8% |
|
DYNAVAX TECHNOLOGIES CORP | 2.5% |
|
AKEBIA THERAPEUTICS INC | 2.3% |
PBE Underweight Relative to FTXH
|
MERCK & CO. INC. | -7.6% |
|
JOHNSON & JOHNSON | -7.1% |
|
ABBVIE INC | -6.6% |
|
BRISTOL-MYERS SQUIBB CO | -6.4% |
|
PFIZER INC | -6.4% |
|
ELI LILLY & CO | -4.5% |
|
CARDINAL HEALTH INC | -4.4% |
|
VIATRIS, INC. | -3.1% |
 |
JAZZ PHARMACEUTICALS PLC | -2.5% |
|
ZOETIS INC | -2.5% |